Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2051250082) titled 'REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults' on Aug. 1.

Study Type: Interventional

Study Design: randomized controlled trial, single blind, active control, parallel assignment, treatment purpose

Primary Sponsor: Kithcart Aaron

Condition: Venous Thromboembolism

Intervention: -REGN7508 (IV REGN7508, IV Placebo, SC REGN7508: SC REGN7508), Administered per the protocol -Apixaban (IV Placebo, apixaban): Administered per the protocol -Enoxaparin (IV Placebo, enoxaparin): Administered per the protocol -Placebo (IV Placebo, SC REGN7508, IV Placebo, apix...